2m 2m 2m 2m 2m 2m 2m
Q32 BIO (QTTB)
NASDAQ
$20.05-$1.33 (-6.22%)
Price as of Jul 14, 2026 8:40 AM EDT- $362.5MMarket Cap
- 953.20%1-Year Change
- BiotechnologyIndustry
Q32 BIO (QTTB)
$20.05-$1.33 (-6.22%)
QTTB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.38 | ||
Change | +$10.17 (+90.72%) | ||
Open | $18.31 | ||
High | $22.50 | ||
Low | $17.28 | ||
Previous Close | $11.21 | ||
Volume | 27,866,895 | ||
30-Day Average Volume | 1,976,075 | ||
1-Week Change | 66.19% | ||
1-Month Change | 69.15% | ||
1-Year Change | 953.20% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 17.0M | ||
Total Assets | $63.7M | ||
Market Cap | $362.5M | ||
Enterprise Value | $320.0M | ||
Period: QTR TTM FY | |||
Revenue | -$192,000.00 | ||
Net Income | -$7.6M | ||
Free Cash Flow | -$6.3M | ||
EBIT | -$7.4M | ||
EBITDA | -$7.3M | ||
Net Working Capital | $46.5M | ||
EPS | -$0.54 | ||
Enterprise Value/EBITDA | -44 | ||
Enterprise Value/Revenue | -1,666 | ||
P/B | 8 | ||
P/E | -40 | ||
PEG | 0 | ||
Price/Free Cash Flow | -57 | ||
Price/Operating Cash Flow | -57 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue